Amal K. Suleiman
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 8
-
- Pharmaceutical Economics and Policy 4
-
- Vaccine Coverage and Hesitancy 3
-
- Health and Well-being Studies 2
-
- Pharmaceutical industry and healthcare 2
-
- Patient Safety and Medication Errors 2
-
- COVID-19 Clinical Research Studies 2
-
- Pharmaceutical Quality and Counterfeiting 2
Amal K. Suleiman
25 papers receiving 291 citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Applied Microbiology and Biotechnology 16
- Geriatrics and Gerontology 30
- Family Practice 6
- Complementary and alternative medicine 22
- Leadership and Management 3
Countries citing papers authored by Amal K. Suleiman
This map shows the geographic impact of Amal K. Suleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal K. Suleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal K. Suleiman more than expected).
Fields of papers citing papers by Amal K. Suleiman
This network shows the impact of papers produced by Amal K. Suleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal K. Suleiman. The network helps show where Amal K. Suleiman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amal K. Suleiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 2 | |
| 13 | 2019 | 24 | |
| 14 | 2017 | 6 | |
| 15 | 2016 | 1 | |
| 16 | 2015 | 19 | |
| 17 | 2015 | 3 | |
| 18 | 2015 | 31 | |
| 19 | 2014 | 70 | |
| 20 | 2013 | 11 |
About Amal K. Suleiman
Amal K. Suleiman is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Family Practice, having authored 32 papers that have together received 307 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (8 papers), Pharmaceutical Economics and Policy (4 papers), Vaccine Coverage and Hesitancy (3 papers), Health and Well-being Studies (2 papers), Pharmaceutical industry and healthcare (2 papers), Patient Safety and Medication Errors (2 papers), COVID-19 Clinical Research Studies (2 papers) and Pharmaceutical Quality and Counterfeiting (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (16 citations), Geriatrics and Gerontology (30 citations) and Family Practice (6 citations). Amal K. Suleiman has collaborated with scholars based in Saudi Arabia, Malaysia and Pakistan. Frequent co-authors include Tahir Mehmood Khan, Long Chiau Ming, Promise Madu Emeka, Hisham Aljadhey, Kai Bin Liew, Fahad Riaz Choudhry, Yaser Mohammed Al‐Worafi, Khadeeja Munawar, Kah Seng Lee and Nurolaini Kifli.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.